NCT01103310View on ClinicalTrials.gov

Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Diagnostic ImagingNeoplasms
Interventions
DRUG

BAY94-9392

Trial Locations (3)

81675

München

94305

Stanford

138-736

Seoul

Sponsors
All Listed Sponsors
lead

Life Molecular Imaging SA

INDUSTRY

NCT01103310 - Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation | Biotech Hunter | Biotech Hunter